MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

The Lancet

July 1, 2002

10.1016/s0140-6736(02)09327-3

Cited by 7,009

Abstract

Related Papers

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

The Heart Outcomes Prevention Evaluation Study Investigators|New England Journal of Medicine|2000|8.7k

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

Richard Peto, M. C. Pike, P. Armitage et al.|British Journal of Cancer|1977|8.4k

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Antiplatelet Trialists Collaboration|BMJ|2002|7k

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group|New England Journal of Medicine|1998|5.3k

Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

Jeremiah Stamler, Olga Vaccaro, James D. Neaton et al.|Diabetes Care|1993|4.1k